Control of Parathyroid Hormone Secretion by its Key Physiological Regulators

The Parathyroids: Basic and Clinical Concepts: Third Edition

Volumn , Issue , 2015, Pages 101-118

  Brown, Edward M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

1,25 dihydroxyvitamin D 1,25(OH2D3 ; Calcium (Ca2+); Calcium sensing receptor (CaSR); Fibroblast growth factor 23 (FGF23); Hormonal degradation; Messenger RNA (mRNA); Parathyroid cell; Parathyroid hormone (PTH); Phosphate; Proliferation; Secretion; Vitamin D receptor (VDR)

Indexed keywords

EID: 84942194725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397166-1.00006-0     Document Type: Chapter

References (139)

1. Brown E.M. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 2007, 3:122-133.
2. Bringhurst F.R., Demay M.B., Kronenberg H.M. Hormones and disorders of mineral metabolism. Williams Textbook of Endocrinology 1998, 1155-1209. W.B. Saunders, Philadelphia. 9th ed. J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen (Eds.).
3. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008, 359:391-403.
4. Huan J., Martuseviciene G., Olgaard K., Lewin E. Calcium-sensing receptor and recovery from hypocalcaemia in thyroparathyroidectomized rats. Eur J Clin Invest 2007, 37:214-221.
5. Neuman W.F. Blood: bone equilibrium. Calcif Tiss Int 1982, 34:117-120.
6. Ward B.K., Magno A.L., Walsh J.P., Ratajczak T. The role of the calcium-sensing receptor in human disease. Clin Biochem 2012, 45:943-953.
7. Schwarz P., Sorensen H.A., McNair P., Transbol I. Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study. Eur J Clin Invest 1993, 23:546-553.
8. Jung A., Mayer G.P., Hurst J.G., Neer R., Potts J.T. Model for parathyroid hormone secretion and metabolism in calves. Am J Physiol 1982, 242:R141-R150.
9. Morrissey J.J., Hamilton J.W., MacGregor R.R., Cohn D.V. The secretion of parathormone fragments 34-84 and 37-84 by dispersed porcine parathyroid cells. Endocrinology 1980, 107:164-171.
10. Brown E.M., Leombruno R., Thatcher J., Burrowes M. The acute secretory response to alterations in the extracellular calcium concentration and dopamine in perifused bovine parathyroid cells. Endocrinology 1985, 116:1123-1132.
11. Morrissey J.J., Cohn D.V. Regulation of secretion of parathormone and secretory protein protein-I from separate intracellular pools by calcium, dibutyryl cyclic AMP, and (l)-isoproterenol. J Cell Biol 1979, 82:93-102.
12. Morrissey J.J., Cohn D.V. Secretion and degradation of parathormone as a function of intracellular maturation of hormone pools. Modulation by calcium and dibutyryl cyclic AMP. J Cell Biol 1979, 83:521-528.
13. Naveh-Many T., Friedlaender M.M., Mayer H., Silver J. Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 1989, 125:275-280.
14. Denda M., Finch J., Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 1996, 28:596-602.
15. Goodman W.G., Quarles L.D. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int 2008, 74:276-288.
16. Schaffler M.B., Cheung W.Y., Majeska R., Kennedy O. Osteocytes: master orchestrators of bone. Calcif Tissue Int 2014, 94:5-224.
17. Hu M.C., Shiizaki K., Kuro-o M., Moe O.W. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 2013, 75:503-533.
18. Demay M.B. Physiological insights from the vitamin D receptor knockout mouse. Calcif Tissue Int 2013, 92:99-105.
19. Silver J., Naveh-Many T. Phosphate and the parathyroid. Kidney Int 2009, 75(9):898-905.
20. Silver J., Rodriguez M., Slatopolsky E. FGF23 and PTH-double agents at the heart of CKD. Nephrol Dial Transplant 2012, 27:1715-1720.
21. Lavi-Moshayoff V., Wasserman G., Meir T., Silver J., Naveh-Many T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010, 299:F882-F889.
22. Habener J.F., Amherdt M., Ravazzola M., Orci L. Parathyroid hormone biosynthesis. Correlation of conversion of biosynthetic precursors with intracellular protein migration as determined by electron microscope autoradiography. J Cell Biol 1979, 80:715-731.
23. Morrissey J.J., Cohn D.V. The effects of calcium and magnesium on the secretion of parathormone and parathyroid secretory protein by isolated porcine parathyroid cells. Endocrinology 1978, 103:2081-2090.
24. Brown E.M., Hurwitz S., Aurbach G.D. Preparation of viable isolated bovine parathyroid cells. Endocrinology 1976, 99:1582-1588.
25. Brown E.M., Gardner D.G., Windeck R.A., Hurwitz S., Brennan M.F., Aurbach G.D. β-Adrenergically stimulated adenosine 3',5'-monophosphate accumulation in and parathyroid hormone release from dispersed human parathyroid cells. J Clin Endocrinol Metab 1979, 48:618-626.
26. Brown E.M. Four parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983, 56:572-581.
27. Nesbit M.A., Hannan F.M., Howles S.A., et al. Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N Engl J Med 2013, 368:2476-2486.
28. Conlin P.R., Fajtova V.T., Mortensen R.M., LeBoff M.S., Brown E.M. Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans. J Clin Endocrinol Metab 1989, 69:593-599.
29. Cunningham J., Altmann P., Gleed J., Butter K., Marsh F., O'Riordan J. Effect of direction and rate of change of calcium on parathyroid hormone secretion in uremia. Nephrol Dial Transplant 1989, 4:339-344.
30. Grant F.D., Conlin P.R., Brown E.M. Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans. J Clin Endocrinol Metab 1990, 71:370-378.
31. Brown E.M., MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001, 81:239-297.
32. Magno A.L., Ward B.K., Ratajczak T. The calcium-sensing receptor: a molecular perspective. Endocr Rev 2011, 32:3-30.
33. Conigrave A.D., Ward D.T. Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab 2013, 27:315-331.
34. Brown E.M., Gamba G., Riccardi D., et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993, 366:575-580.
35. 2+ in bovine parathyroid cells by external divalent cations. J Biol Chem 1987, 202:5188-5196.
36. Shoback D.M., Chen T.H., Lattyak B., King K., Johnson R.M. Effects of high extracellular calcium and strontium on inositol polyphosphates in bovine parathyroid cells. J Bone Miner Res 1993, 8:891-898.
37. Brown E.M. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991, 71:371-411.
38. Chakravarti B., Chattopadhyay N., Brown E.M. Signaling through the extracellular calcium-sensing receptor (CaSR). Adv Exp Med Biol 2012, 740:103-142.
39. Chen C., Barnett J., Congo D., Brown E. Divalent cations suppress 3',5'-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells. Endocrinology 1989, 124:233-239.
40. Brauner-Osborne H., Wellendorph P., Jensen A.A. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets 2007, 8:169-184.
41. Garrett J.E., Capuano I.V., Hammerland L.G., Hung B.C., Brown E.M., Hebert S.C., et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995, 270:12919-12925.
42. Fan G.F., Ray K., Zhao X.M., Goldsmith P.K., Spiegel A.M. Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett 1998, 436:353-356.
43. Pidasheva S., Grant M., Canaff L., Ercan O., Kumar U., Hendy G.N. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum Mol Genet 2006, 15:2200-2209.
44. Grant M.P., Stepanchick A., Cavanaugh A., Breitwieser G.E. Agonist-driven maturation and plasma membrane insertion of calcium-sensing receptors dynamically control signal amplitude. Sci Signal 2011, 4. ra78.
45. Nesbit M.A., Hannan F.M., Howles S.A., Reed A.A., Cranston T., Thakker C.E., et al. Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 2013, 45:93-97.
46. Hu J., Spiegel A.M. Naturally occurring mutations in the extracellular Ca2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metabol 2003, 14:282-288.
47. Huang Y., Zhou Y., Castiblanco A., Yang W., Brown E.M., Yang J.J. Multiple Ca(2+)-binding sites in the extracellular domain of the Ca(2+)-sensing receptor corresponding to cooperative Ca(2+) response. Biochemistry 2009, 48:388-398.
48. Silve C., Petrel C., Leroy C., Bruel H., Mallet E., Rognan D., et al. Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005, 280:37917-37923.
49. Geibel J., Sritharan K., Geibel R., Geibel P., Persing J.S., Seeger A., et al. Calcium-sensing receptor abrogates secretagogue-induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction. Proc Natl Acad Sci USA 2006, 103:9390-9397.
50. Fox J., Lowe S.H., Petty B.A., Nemeth E.F. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. J Pharmacol Exp Ther 1999, 290:473-479.
51. Nemeth E.F., Steffey M.E., Hammerland L.G., Hung B.C., Van Wegenen B.C., DelMar E.G., et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998, 95:4040-4045.
52. Huang Y., Breitwieser G.E. Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis. J Biol Chem 2007, 282:9517-9525.
53. Leach K., Wen A., Cook A.E., Sexton P.M., Conigrave A.D., Christopoulos A. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators. Endocrinology 2013, 154:1105-1116.
54. Ho C., Conner D.A., Pollak M.R., Ladd D.J., Kifor O., Warren H.B., et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism [see comments]. Nat Genet 1995, 11:389-394.
55. Wettschureck N., Lee E., Libutti S.K., Offermanns S., Robey P.G., Spiegel A.M. Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+-sensing receptor. Mol Endocrinol 2007, 21:274-280.
56. Bourdeau A., Souberbielle J.-C., Bonnet P., Herviaux P., Sachs C., Lieberherr M. Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion. Endocrinology 1992, 130:1339-1344.
57. Bourdeau A., Moutahir M., Souberbielle J.C., Bonnet P., Herviaux P., Sachs C., et al. Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion. Endocrinology 1994, 135:1109-1112.
58. Corbetta S., Lania A., Filopanti M., Vincentini L., Ballare E., Spada A. Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab 2002, 87:2201-2205.
59. Lu M., Forsberg L., Höög A., Juhlin C.C., Vukojević V., Larsson C., et al. Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue. Mol Cell Endocrinol 2008, 287:72-80.
60. Quinn S.J., Kifor O., Kifor I., Butters R.R., Brown E.M. Role of the cytoskeleton in extracellular calcium-regulated PTH release. Biochem Biophys Res Commun 2007, 354:8-13.
61. Nemeth E.F., Shoback D. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders. Best Pract Res Clin Endocrinol Metab 2013, 27:373-384.
62. Mendoza F.J., Lopez I., Canalejo R., Almaden Y., Martin D., Aguilera-Tejero E., et al. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats. Am J Physiol Renal Physiol 2009, 296:F605-F613.
63. Nielsen P.K., Rasmussen A.K., Butters R., Feldt-Rasmussen U., Bendtzen K., Diaz R., et al. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium- sensing receptor mRNA. Biochem Biophys Res Commun 1997, 238:880-885.
64. Canaff L., Zhou X., Hendy G.N. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem 2008, 283:13586-13600.
65. Murphey E.D., Chattopadhyay N., Bai M., Kifor O., Harper D., Traber D.L., et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med 2000, 28:3885-3890.
66. Maiti A., Beckman M.J. Extracellular calcium is a direct effecter of VDR levels in proximal tubule epithelial cells that counter-balances effects of PTH on renal vitamin D metabolism. J Steroid Biochem Mol Biol 2007, 103:504-508.
67. Cholst I., Steinberg S., Tropper P., Fox H., Segre G. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984, 310:1221-1225.
68. Conigrave A.D., Mun H.C., Brennan S.C. Physiological significance of L-amino acid sensing by extracellular Ca(2+)-sensing receptors. Biochem Soc Trans 2007, 35:1195-1198.
69. Conigrave A.D., Mun H.C., Lok H.C. Aromatic L-amino acids activate the calcium-sensing receptor. J Nutr 2007, 137:1524S-1527S. discussion 1548S.
70. D'Amour P. Circulating PTH molecular forms: what we know and what we don't. Kidney Int Suppl 2006, S29-S33.
71. Mayer G.P., Keaton J.A., Hurst J.G., Habener J.F. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 1979, 104:1778-1784.
72. Hanley D., Takatsuki K., Sultan J., Schneider A., Sherwood L. Direct release of parathyroid hormone fragments from functioning bovine parathyroid glands in vitro. J Clin Invest 1978, 62:1247-1254.
73. Segre G.V., Niall H.D., Sauer R.T., Potts J.T. Edman degradation of radioiodinated parathyroid hormone: application to sequence analysis and hormone metabolism in vivo. Biochemistry 1977, 16:2417-2427.
74. D'Amour P., Rakel A., Brossard J.H., Rousseau L., Albert C., Cantor T. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays. J Clin Endocrinol Metab 2006, 91:283-289.
75. Nussbaum S.R., Zahradnik R.J., Lavigne J.R., Brennan G.L., Nozawa-Ung K., Kim L.Y., et al. A highly sensitive two-site immunoradiometric assay for parathyroid hormone (PTH) and its clinical utility in the evaluation of patients with hypercalcemia. Clin Chem 1987, 33:1364-1367.
76. Gao P., Scheibel S., D'Amour P., John M.R., Rao S.D., Schmidt-Gayk H., et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001, 16:605-614.
77. Friedman P.A., Goodman W.G. PTH(1-84)/PTH(7-84): a balance of power. Am J Physiol Renal Physiol 2006, 290:F975-F984.
78. Schwarz P., Sorensen H.A., Transbol I., McNair P. Regulation of acute parathyroid hormone release in normal humans: combined calcium and citrate clamp study. Am J Physiol 1992, 263:E195-E198.
79. Jung A., Mayer G.P., Hurst J.G., Neer R., Potts J.T. Model for parathyroid hormone secretion and metabolism in calves. Am J Physiol 1982, 242:R141-R150.
80. Valle C., Rodriguez M., Santamaría R., Almaden Y., Rodriguez M.E., Cañadillas S., et al. Cinacalcet reduces the set point of the PTH-calcium curve. J Am Soc Nephrol 2008, 19:2430-2436.
81. Nechama M., Ben-Dov I.Z., Silver J., Naveh-Many T. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. Am J Physiol Renal Physiol 2009, 296:F795-F800.
82. Nechama M., Peng Y., Bell O., Briata P., Gherzi R., Schoenberg D.R., et al. KSRP-PMR1-exosome association determines parathyroid hormone mRNA levels and stability in transfected cells. BMC Cell Biol 2009, 10:70.
83. Levi R., Ben-Dov I.Z., Lavi-Moshayoff V., Dinur M., Martin D., Naveh-Many T., et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 2006, 17:107-112.
84. Raisz L. Regulation by calcium of parathyroid growth and secretion in vitro. Nature 1965, 44:103-110.
85. Roth S.I., Raisz L.G. The course and reversibility of the calcium effect on the ultrastructure of the rat parathyroid gland in organ culture. Lab Invest 1966, 15:1187-1211.
86. Egbuna O.I., Brown E.M. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008, 22:129-148.
87. Wada M., Furuya Y., Sakiyama J., Kobayashi N., Miyata S., Ishii H., et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. J Clin Invest 1997, 100:2977-2983.
88. Finch J.L., Lee D.H., Liapis H., Ritter C., Zhang S., Suarez E., et al. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification. Kidney Int 2013, 84:1145-1153.
89. Arcidiacono M.V., Sato T., Alvarez-Hernandez D., Yang J., Tokumoto M., Gonzalez-Suarez I., et al. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol 2008, 19:310-320.
90. Dusso A.S., Pavlopoulos T., Naumovich L., Lu Y., Finch J., Brown A.J., et al. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001, 59:855-865.
91. Gogusev J., Duchambon P., Stoermann-Chopard C., Giovannini M., Sarfati E., Drueke T.B. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 1996, 11:2155-2162.
92. Cozzolino M., Lu Y., Sato T., Yang J., Suarez I.G., Brancaccio D., et al. A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol 2005, 289:F1096-F1102.
93. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001, 3:802-808.
94. Kanesaka Y., Tokunaga H., Iwashita K., Fujimura S., Naomi S., Tomita K. Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats. Endocrinology 2001, 142:407-413.
95. Cozzolino M., Lu Y., Finch J., Slatopolsky E., Dusso A.S. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 2001, 60:2109-2117.
96. Wang Q., Palnitkar S., Parfitt A.M. Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery. Endocrinology 1996, 137:4558-4562.
97. Colloton M., Shatzen E., Miller G., Stehman-Breen C., Wada M., Lacey D., et al. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 2005, 67:467-476.
98. Mizobuchi M., Ogata H., Hatamura I., Saji F., Koiwa F., Kinugasa E., et al. Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells. Biochem Biophys Res Commun 2007, 362:11-16.
99. Roth S.I. Recent advances in parathyroid gland pathology. Am J Med 1971, 50:612-622.
100. Roth S.I., Raisz L.G. The course and reversibility of calcium effect on the ultrastructure of the rat parathyroid gland in organ culture. Lab Invest 1966, 15:1187-1211.
101. Brown E.M., Wilson R.E., Thatcher J.G., Marynick S.P. Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med 1981, 71:565-570.
102. Bourdeau A., Atmani F., Grosse B., Lieberherr M. Rapid effects of 1,25-dihydroxyvitamin D3 and extracellular Ca2+ on phospholipid metabolism in dispersed porcine parathyroid cells. Endocrinology 1990, 127:2738-2743.
103. Sugimoto T., Ritter C., Ried I., Morrissey J., Slatopolsky E. Effect of 1,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed parathyroid cells. Kidney Int 1988, 33:850-854.
104. Segersten U., Correa P., Hewison M., Hellman P., Dralle H., Carling T., et al. 25-Hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 2002, 87:2967-2972.
105. Silver J., Russell J., Sherwood L.M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985, 82:4270-4273.
106. Silver J., Naveh-Many T., Mayer H., Schmelzer H.J., Popovtzer M.M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986, 78:1296-1301.
107. Naveh-Many T., Marx R., Keshet E., Pike J.W., Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid gland in vivo. J Clin Invest 1990, 86:1969-1975.
108. Okazaki T., Igarashi T., Kronenberg H.M. 5'-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem 1988, 263:2203-2208.
109. Kim M.S., Fujiki R., Murayama A., Kitagawa H., Yamaoka K., Yamamoto Y., et al. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol 2007, 21:334-342.
110. Canalejo A., Almadén Y., Torregrosa V., Gomez-Villamandos J.C., Ramos B., Campistol J.M., et al. The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. J Am Soc Nephrol 2000, 11:1865-1872.
111. Kremer R., Bolivar I., Goltzman D., Hendy G.N. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989, 125:935-941.
112. Dusso A., Cozzolino M., Lu Y., Sato T., Slatopolsky E. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol 2004, 89-90. 507-11.
113. Shiizaki K., Negi S., Mizobuchi M., Hatamura I., Narukawa N., Sakaguchi T., et al. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 2003, 18(Suppl. 3):iii42-iii46.
114. Shiizaki K., Hatamura I., Negi S., Sakaguchi T., Saji F., Imazeki I., et al. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland-study in rats. Nephrol Dial Transplant 2008, 23:1529-1536.
115. Mizobuchi M., Saji F., Shiizaki K., Sato T., Shibata M., Negi S., et al. Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics. Clin Calcium 2005, 15(Suppl. 1):56-58. discussion 58-9.
116. Li Y.C., Amling M., Pirro A.E., Priemel M., Meuse J., Baron R., et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139:4391-4396.
117. Meir T., Levi R., Lieben L., Libutti S., Carmeliet G., Bouillon R., et al. Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol Renal Physiol 2009, 297:F1192-F1198.
118. Demay M.B. Mechanism of vitamin D receptor action. Ann NY Acad Sci 2006, 1068:204-213.
119. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766.
120. Silver J., Dranitzki-Elhalel M. Sensing phosphate across the kingdoms. Curr Opin Nephrol Hypertens 2003, 12:357-361.
121. Canalejo A., Canadillas S., Ballesteros E., Rodriguez M., Almaden Y. Importance of arachidonic acid as a mediator of parathyroid gland response. Kidney Int Suppl 2003, S10-S13.
122. Almaden Y., Canalejo A., Ballesteros E., Anon G., Canadillas S., Rodriguez M. Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: effect of extracellular phosphate. J Am Soc Nephrol 2002, 13:693-698.
123. Slatopolsky E., Brown A., Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 2001, 37:S54-S57.
124. Slatopolsky E., Finch J., Denda M., Ritter C., Zhong M., Dusso A., et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996, 97:2534-2540.
125. Care A.D., Sherwood L.M., Potts J.T., Aurbach G.D. Perfusion of the isolated parathyroid gland of the goat and sheep. Nature 1966, 209:55-57.
126. Silver J., Levi R. Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 2005, 63:119-126.
127. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001, 98:6500-6505.
128. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000, 26:345-348. ADHR Consortium.
129. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004, 19:429-435.
130. Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V., Goetz R., Kuro-o M., Mohammadi M., et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007, 117:4003-4008.
131. Kawata T., Imanishi Y., Kobayashi K., Miki T., Arnold A., Inaba M., et al. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 2007, 18:2683-2688.
132. Berndt T., Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 2009, 24:17-25.
133. Juppner H. Novel regulators of phosphate homeostasis and bone metabolism. Ther Apher Dial 2007, 11(Suppl. 1):S3-22.
134. Takeshita K., Fujimori T., Kurotaki Y., Honjo H., Tsujikawa H., Yasui K., et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004, 109:1776-1782.
135. Krajisnik T., Olauson H., Mirza M.A., Hellman P., Akerström G., Westin G., et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010, 78:1024-1032.
136. Nabeshima Y. The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell Mol Life Sci 2008, 65:3218-3230.
137. Komaba H., Fukagawa M. The role of FGF23 in CKD-with or without Klotho. Nat Rev Nephrol 2013, 8:484-490.
138. Galitzer H., Ben-Dov I.Z., Silver J., Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010, 77:211-218.
139. Komaba H., Goto S., Fujii H., Hamada Y., Kobayashi A., Shibuya K., et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010, 77:232-238.